REVOLUTION MEDICINES INC (NASDAQ:RVMD) is a clinical-stage precision oncology company that has surged into the spotlight of technical breakout screens, thanks to a combination of strong trending behavior and a tightening consolidation pattern. The methodology behind the Technical Breakout Setups screen is straightforward: it identifies stocks that simultaneously earn high scores on two proprietary ChartMill ratings — the Technical Rating, which measures overall technical health and trend strength, and the Setup Quality Rating, which gauges the presence of a well???defined consolidation or base. Revolution Medicines’ current scores of 9 out of 10 on both metrics place it squarely in breakout territory.
Why the Technical Rating Matters
A high Technical Rating signals that a stock is not merely rising but doing so in a sustained, orderly fashion. Revolution Medicines earns its 9 rating from several confirming factors:
- The long???term trend is positive, with the stock trading well above its 200???day moving average ($114.03) and its 50???day moving average ($169.85).
- The stock is near its 52???week high of $194.56, a hallmark of relative strength. The S&P 500, meanwhile, is in a neutral long???term trend and only positive in the short term — meaning Revolution Medicines is clearly leading the broader market.
- On a one???year basis, the stock has outperformed 99% of all U.S. equities, and gains have been smoothly distributed rather than concentrated in a few sharp moves.
- Within the Biotechnology industry (507 stocks), Revolution Medicines ranks in the top 4%.
These elements combine to give the stock a robust technical foundation. Investors who want to review the full technical breakdown, including support and resistance levels and moving average trends, can consult the detailed technical analysis report.
The Setup Quality: A Consolidation Ready to Break
While a strong trend is necessary, it is not sufficient. The Setup Quality Rating addresses the “when” of entry by measuring how tightly a stock has traded recently. A high Setup score indicates that prices have paused or pulled back within a narrow range, creating a clean base that can serve as a launchpad. Revolution Medicines scores a 9 here as well, reflecting a clear bull flag pattern — a brief pullback after a strong rally that often resolves upward.
Key setup observations include:
- Current price ($180.92) is just below a resistance zone at $192.62–$192.63. A break above that level could trigger a new leg higher.
- A support zone exists between $177.63 and $180.91, offering a logical place for a stop???loss if the breakout fails.
- Proprietary effective???volume data suggests large players have been accumulating the stock in recent days, adding conviction to the pattern.
- The 20???day average true range is about 3.73%, giving a reasonable buffer for stop placement without being too wide.
This consolidation, combined with the strong technical rating, makes Revolution Medicines a textbook candidate for a breakout trade. The generated trade suggestion (entry near $184.30 with a stop below $177.62) captures the dynamics of the pattern while keeping risk manageable.
Finding More Breakout Candidates
Revolution Medicines is not an isolated case. The same screen that surfaced this stock can be run daily to uncover other equities that combine high Technical Ratings with high Setup Quality Ratings. Traders and investors who want to scan for additional candidates can use the Technical Breakout Setups screen, which applies the same criteria — TA rating ≥ 7, Setup rating ≥ 7, and minimum liquidity thresholds — to the entire market.
As with any technical setup, risks remain. Clinical???stage biotech stocks can react violently to trial data or regulatory news, so checking the earnings calendar and having a disciplined stop???loss plan is essential. Nonetheless, Revolution Medicines’ current technical profile offers a rare blending of trend strength and consolidation, making it worth close attention for those following a breakout???focused strategy.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »
View the Zacks #1 Rank List
Revolution Medicines (NASDAQ:RVMD) Flashes Strong Technical Breakout Setup
REVOLUTION MEDICINES INC (NASDAQ:RVMD) is a clinical-stage precision oncology company that has surged into the spotlight of technical breakout screens, thanks to a combination of strong trending behavior and a tightening consolidation pattern. The methodology behind the Technical Breakout Setups screen is straightforward: it identifies stocks that simultaneously earn high scores on two proprietary ChartMill ratings — the Technical Rating, which measures overall technical health and trend strength, and the Setup Quality Rating, which gauges the presence of a well???defined consolidation or base. Revolution Medicines’ current scores of 9 out of 10 on both metrics place it squarely in breakout territory.
Why the Technical Rating Matters
A high Technical Rating signals that a stock is not merely rising but doing so in a sustained, orderly fashion. Revolution Medicines earns its 9 rating from several confirming factors:
These elements combine to give the stock a robust technical foundation. Investors who want to review the full technical breakdown, including support and resistance levels and moving average trends, can consult the detailed technical analysis report.
The Setup Quality: A Consolidation Ready to Break
While a strong trend is necessary, it is not sufficient. The Setup Quality Rating addresses the “when” of entry by measuring how tightly a stock has traded recently. A high Setup score indicates that prices have paused or pulled back within a narrow range, creating a clean base that can serve as a launchpad. Revolution Medicines scores a 9 here as well, reflecting a clear bull flag pattern — a brief pullback after a strong rally that often resolves upward.
Key setup observations include:
This consolidation, combined with the strong technical rating, makes Revolution Medicines a textbook candidate for a breakout trade. The generated trade suggestion (entry near $184.30 with a stop below $177.62) captures the dynamics of the pattern while keeping risk manageable.
Finding More Breakout Candidates
Revolution Medicines is not an isolated case. The same screen that surfaced this stock can be run daily to uncover other equities that combine high Technical Ratings with high Setup Quality Ratings. Traders and investors who want to scan for additional candidates can use the Technical Breakout Setups screen, which applies the same criteria — TA rating ≥ 7, Setup rating ≥ 7, and minimum liquidity thresholds — to the entire market.
As with any technical setup, risks remain. Clinical???stage biotech stocks can react violently to trial data or regulatory news, so checking the earnings calendar and having a disciplined stop???loss plan is essential. Nonetheless, Revolution Medicines’ current technical profile offers a rare blending of trend strength and consolidation, making it worth close attention for those following a breakout???focused strategy.
Disclaimer: This article is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Always conduct your own research and consider your risk tolerance before making investment decisions.
Read full article here »